Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019

Objective This study was designed to identify the risk factors for drug-resistant tuberculosis (DR-TB) and the association between comorbidity and drug resistance among retreated pulmonary tuberculosis (PTB).Design A retrospective study was conducted among all the 36 monitoring sites in Shandong, Ch...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi-Fan Li, Ning-ning Tao, Wan-mei Song, Jin-yue Liu, Qian-yun Zhang, Ting-ting Xu, Shi-jin Li, Qi-qi An, Si-qi Liu, Huai-chen Li
Format: Article
Language:English
Published: BMJ Publishing Group 2021-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/6/e044349.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846162988743000064
author Yi-Fan Li
Ning-ning Tao
Wan-mei Song
Jin-yue Liu
Qian-yun Zhang
Ting-ting Xu
Shi-jin Li
Qi-qi An
Si-qi Liu
Huai-chen Li
author_facet Yi-Fan Li
Ning-ning Tao
Wan-mei Song
Jin-yue Liu
Qian-yun Zhang
Ting-ting Xu
Shi-jin Li
Qi-qi An
Si-qi Liu
Huai-chen Li
author_sort Yi-Fan Li
collection DOAJ
description Objective This study was designed to identify the risk factors for drug-resistant tuberculosis (DR-TB) and the association between comorbidity and drug resistance among retreated pulmonary tuberculosis (PTB).Design A retrospective study was conducted among all the 36 monitoring sites in Shandong, China, over a 16-year period. Baseline characteristics were collected from the TB Surveillance System. Categorical variables were compared by Fisher’s exact or Pearson’s χ2 test. The risk factors for drug resistance were identified using univariable analysis and multivariable logistic models. The influence of comorbidity on different types of drug resistance was evaluated by performing multivariable logistic models with the covariates adjusted by age, sex, body mass index, drinking/smoking history and cavity.Results A total of 10 975 patients with PTB were recorded during 2004–2019, and of these 1924 retreated PTB were finally included. Among retreated PTB, 26.2% were DR-TB and 12.5% had comorbidity. Smoking (adjusted OR (aOR): 1.69, 95% CI 1.19 to 2.39), cavity (aOR: 1.55, 95% CI 1.22 to 1.97) and comorbidity (aOR: 1.44, 95% CI 1.02 to 2.02) were risk factors for DR-TB. Of 504 DR-TB, 9.5% had diabetes mellitus, followed by hypertension (2.0%) and chronic obstructive pulmonary disease (1.8%). Patients with retreated PTB with comorbidity were more likely to be older, have more bad habits (smoking, alcohol abuse) and have clinical symptoms (expectoration, haemoptysis, weight loss). Comorbidity was significantly associated with DR-TB (aOR: 1.44, 95% CI 1.02 to 2.02), overall rifampin resistance (aOR: 2.17, 95% CI 1.41 to 3.36), overall streptomycin resistance (aOR: 1.51, 95% CI 1.00 to 2.27) and multidrug resistance (aOR: 1.96, 95% CI 1.17 to 3.27) compared with pan-susceptible patients (p<0.05).Conclusion Smoking, cavity and comorbidity lead to an increased risk of drug resistance among retreated PTB. Strategies to improve the host’s health, including smoking cessation, screening and treatment of comorbidity, might contribute to the control of tuberculosis, especially DR-TB, in China.
format Article
id doaj-art-985ba7d806dc4bccaf20c7b8cffdd97b
institution Kabale University
issn 2044-6055
language English
publishDate 2021-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-985ba7d806dc4bccaf20c7b8cffdd97b2024-11-19T21:05:08ZengBMJ Publishing GroupBMJ Open2044-60552021-06-0111610.1136/bmjopen-2020-044349Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019Yi-Fan Li0Ning-ning Tao1Wan-mei Song2Jin-yue Liu3Qian-yun Zhang4Ting-ting Xu5Shi-jin Li6Qi-qi An7Si-qi Liu8Huai-chen Li92 Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, ChinaDepartment of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China1 Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital, Jinan, Shandong, China4 Department of Medical Ultrasound, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Abdominal Medical Imaging, Jinan, Shandong, China1 Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital, Jinan, Shandong, China1 Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital, Jinan, Shandong, China3 Department of Respiratory Medicine, Chengwu People`s Hospital, Heze, Shandong, China1 Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital, Jinan, Shandong, ChinaDepartment of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China1 Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital, Jinan, Shandong, ChinaObjective This study was designed to identify the risk factors for drug-resistant tuberculosis (DR-TB) and the association between comorbidity and drug resistance among retreated pulmonary tuberculosis (PTB).Design A retrospective study was conducted among all the 36 monitoring sites in Shandong, China, over a 16-year period. Baseline characteristics were collected from the TB Surveillance System. Categorical variables were compared by Fisher’s exact or Pearson’s χ2 test. The risk factors for drug resistance were identified using univariable analysis and multivariable logistic models. The influence of comorbidity on different types of drug resistance was evaluated by performing multivariable logistic models with the covariates adjusted by age, sex, body mass index, drinking/smoking history and cavity.Results A total of 10 975 patients with PTB were recorded during 2004–2019, and of these 1924 retreated PTB were finally included. Among retreated PTB, 26.2% were DR-TB and 12.5% had comorbidity. Smoking (adjusted OR (aOR): 1.69, 95% CI 1.19 to 2.39), cavity (aOR: 1.55, 95% CI 1.22 to 1.97) and comorbidity (aOR: 1.44, 95% CI 1.02 to 2.02) were risk factors for DR-TB. Of 504 DR-TB, 9.5% had diabetes mellitus, followed by hypertension (2.0%) and chronic obstructive pulmonary disease (1.8%). Patients with retreated PTB with comorbidity were more likely to be older, have more bad habits (smoking, alcohol abuse) and have clinical symptoms (expectoration, haemoptysis, weight loss). Comorbidity was significantly associated with DR-TB (aOR: 1.44, 95% CI 1.02 to 2.02), overall rifampin resistance (aOR: 2.17, 95% CI 1.41 to 3.36), overall streptomycin resistance (aOR: 1.51, 95% CI 1.00 to 2.27) and multidrug resistance (aOR: 1.96, 95% CI 1.17 to 3.27) compared with pan-susceptible patients (p<0.05).Conclusion Smoking, cavity and comorbidity lead to an increased risk of drug resistance among retreated PTB. Strategies to improve the host’s health, including smoking cessation, screening and treatment of comorbidity, might contribute to the control of tuberculosis, especially DR-TB, in China.https://bmjopen.bmj.com/content/11/6/e044349.full
spellingShingle Yi-Fan Li
Ning-ning Tao
Wan-mei Song
Jin-yue Liu
Qian-yun Zhang
Ting-ting Xu
Shi-jin Li
Qi-qi An
Si-qi Liu
Huai-chen Li
Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019
BMJ Open
title Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019
title_full Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019
title_fullStr Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019
title_full_unstemmed Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019
title_short Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019
title_sort risk factors for drug resistant tuberculosis the association between comorbidity status and drug resistant patterns a retrospective study of previously treated pulmonary tuberculosis in shandong china during 2004 2019
url https://bmjopen.bmj.com/content/11/6/e044349.full
work_keys_str_mv AT yifanli riskfactorsfordrugresistanttuberculosistheassociationbetweencomorbiditystatusanddrugresistantpatternsaretrospectivestudyofpreviouslytreatedpulmonarytuberculosisinshandongchinaduring20042019
AT ningningtao riskfactorsfordrugresistanttuberculosistheassociationbetweencomorbiditystatusanddrugresistantpatternsaretrospectivestudyofpreviouslytreatedpulmonarytuberculosisinshandongchinaduring20042019
AT wanmeisong riskfactorsfordrugresistanttuberculosistheassociationbetweencomorbiditystatusanddrugresistantpatternsaretrospectivestudyofpreviouslytreatedpulmonarytuberculosisinshandongchinaduring20042019
AT jinyueliu riskfactorsfordrugresistanttuberculosistheassociationbetweencomorbiditystatusanddrugresistantpatternsaretrospectivestudyofpreviouslytreatedpulmonarytuberculosisinshandongchinaduring20042019
AT qianyunzhang riskfactorsfordrugresistanttuberculosistheassociationbetweencomorbiditystatusanddrugresistantpatternsaretrospectivestudyofpreviouslytreatedpulmonarytuberculosisinshandongchinaduring20042019
AT tingtingxu riskfactorsfordrugresistanttuberculosistheassociationbetweencomorbiditystatusanddrugresistantpatternsaretrospectivestudyofpreviouslytreatedpulmonarytuberculosisinshandongchinaduring20042019
AT shijinli riskfactorsfordrugresistanttuberculosistheassociationbetweencomorbiditystatusanddrugresistantpatternsaretrospectivestudyofpreviouslytreatedpulmonarytuberculosisinshandongchinaduring20042019
AT qiqian riskfactorsfordrugresistanttuberculosistheassociationbetweencomorbiditystatusanddrugresistantpatternsaretrospectivestudyofpreviouslytreatedpulmonarytuberculosisinshandongchinaduring20042019
AT siqiliu riskfactorsfordrugresistanttuberculosistheassociationbetweencomorbiditystatusanddrugresistantpatternsaretrospectivestudyofpreviouslytreatedpulmonarytuberculosisinshandongchinaduring20042019
AT huaichenli riskfactorsfordrugresistanttuberculosistheassociationbetweencomorbiditystatusanddrugresistantpatternsaretrospectivestudyofpreviouslytreatedpulmonarytuberculosisinshandongchinaduring20042019